Hereditary spherocytosis (HS; congenital spherocytic haemolytic anaemia)
Haemolytic anaemia · Haematology / Oncology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Inherited red-cell membrane defect (ankyrin/spectrin/band 3) -> spherocytes removed by spleen -> chronic haemolysis, jaundice, splenomegaly, gallstones. Often known from childhood. ED presentations: haemolytic crisis (infection-triggered), aplastic crisis (parvovirus B19), or gallstone complications.
Red flags
- Aplastic crisis: rapidly falling Hb with LOW reticulocytes (parvovirus B19)
- Severe symptomatic anaemia (cardiac compromise)
- Overwhelming post-splenectomy sepsis (asplenic, encapsulated organisms)
- Acute cholecystitis / biliary obstruction from pigment stones
- Megaloblastic crisis from folate depletion
Assessment
Differential diagnosis
- Warm autoimmune haemolytic anaemia (spherocytes too - but DAT positive)
- G6PD deficiency / other enzymopathy
- Other membranopathies (elliptocytosis)
- Neonatal jaundice causes
- Haemolysis from sepsis/DIC
Investigations
- FBC + reticulocytes (raised) + blood film (spherocytes, polychromasia)
- DAT/Coombs - NEGATIVE (distinguishes from autoimmune haemolysis with spherocytes)
- Haemolysis screen: bilirubin (unconjugated) up, LDH up, haptoglobin down
- Raised MCHC is a classic clue; EMA binding test or osmotic fragility / flow cytometry confirms
- Parvovirus B19 serology/PCR if aplastic crisis (low reticulocytes with anaemia)
- USS for gallstones; family history
Management
- Confirm chronic HS vs new autoimmune haemolysis (DAT negative in HS)
- Haemolytic crisis (usually infection-triggered): supportive care, treat trigger, transfuse if symptomatic/severe
- Aplastic crisis (parvovirus B19): reticulocytopenia + falling Hb - transfuse as needed, usually self-limiting over ~1-2 weeks, isolate from pregnant staff/patients
- Folic acid supplementation for chronic haemolysis
- Manage gallstone complications (biliary colic, cholecystitis, pigment stones) on standard pathway
- Splenectomy reserved for severe/transfusion-dependent cases - ensure vaccination (pneumococcal, meningococcal, Hib) + penicillin prophylaxis
- Monitor for megaloblastic change if folate deficient
Drugs & doses
Folic acid 5 mg PO once daily (chronic/ongoing haemolysis)
Transfuse packed red cells for symptomatic/severe anaemia or aplastic crisis (DAT negative - standard cross-match straightforward) [verify local dose]
Pre-splenectomy vaccination: pneumococcal, meningococcal ACWY + B, Hib; lifelong penicillin V 250-500 mg PO twice daily post-splenectomy [verify local dose]
Antibiotics for infective trigger as indicated
Disposition
Significant crisis (haemolytic/aplastic) or symptomatic anaemia -> admit with haematology. Mild/known case with trigger -> treat and discharge with follow-up and folic acid.
Complications & pitfalls
- Pigment gallstones / cholecystitis
- Aplastic crisis (parvovirus B19)
- Megaloblastic crisis (folate deficiency)
- Post-splenectomy sepsis and thrombosis
- Leg ulcers, iron overload if frequently transfused
Exam pearls
- Spherocytes + NEGATIVE DAT + raised MCHC = hereditary spherocytosis; spherocytes + POSITIVE DAT = autoimmune haemolysis
- A sudden drop with low reticulocytes in a known HS patient = parvovirus B19 aplastic crisis, not worsening haemolysis
- Lifelong folic acid prevents megaloblastic crises
- Post-splenectomy patients need vaccination, penicillin prophylaxis and a low threshold for treating fever as sepsis
- Gallstones are common and young - have a low threshold for biliary imaging
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.